1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3

✍ Scribed by Sulkowski, M.; Gardiner, D.; Lawitz, E.; Hinestrosa, F.; Nelson, D.; Thuluvath, P.; Rodriguez-Torres, M.; Lok, A.; Schwartz, H.; Reddy, K.R.; Eley, T.; Wind-Rotolo, M.; Huang, S.-P.; Gao, M.; McPhee, F.; Hindes, R.; Symonds, B.; Pasquinelli, C.; Grasela, D.

• Book ID: 123474618
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 110 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(12)61433-0